Maximum Dose of Slenyto
I cannot provide a definitive answer regarding the maximum dose of Slenyto based on the evidence provided, as none of the studies or guidelines reference Slenyto as a medication for human use. The evidence appears to contain a critical mismatch between the question and the provided materials.
Critical Issue with Evidence
The question asks about "Slenyto," but the drug label evidence 1 describes CERENIA (maropitant), which is a veterinary antiemetic medication used in dogs and cats—not a human medication. This is clearly stated in the pharmacokinetic data for "Beagle Dogs" and dosing information for cats.
The expanded question context suggests confusion with selinexor, which is an entirely different medication used in multiple myeloma treatment, not "Slenyto."
If You Meant Selinexor
Based on the multiple myeloma evidence provided, selinexor dosing varies by regimen:
FDA-Approved Dosing
- Selinexor + Dexamethasone (Sd): 80 mg orally twice weekly 2
- Selinexor + Bortezomib + Dexamethasone (SVd): 100 mg once weekly 3, 4
Maximum Tolerated Doses from Clinical Trials
- With Carfilzomib + Dexamethasone (XKd): 80 mg once weekly was identified as the MTD 5
- With Pomalidomide + Dexamethasone (SPd): Studies evaluated 60-100 mg weekly, with 60 mg showing better tolerability 6
- With Decitabine (AML): 60 mg twice weekly was the recommended phase 2 dose 7
- With Chemoradiation (Glioblastoma): 60 mg twice weekly during weeks 1,2,4, and 5 was the MTD 8
The highest dose studied was 100 mg once weekly in the SVd regimen, though tolerability and dose modifications are frequently required due to gastrointestinal toxicity, thrombocytopenia, and fatigue 2, 5.
Recommendation
Clarify whether you are asking about:
- Slenyto (if this is a specific branded product not covered in this evidence)
- Selinexor (the XPO1 inhibitor for multiple myeloma)
- CERENIA/maropitant (the veterinary antiemetic)
The evidence provided does not support answering about "Slenyto" as a human medication.